Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-033616
Filing Date
2024-11-06
Accepted
2024-11-06 16:10:39
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cont20240930_10q.htm   iXBRL 10-Q 1475935
2 EXHIBIT 31.1 ex_715575.htm EX-31.1 15886
3 EXHIBIT 31.2 ex_715576.htm EX-31.2 12665
4 EXHIBIT 32.1 ex_715577.htm EX-32.1 9094
5 EXHIBIT 32.2 ex_715578.htm EX-32.2 6101
11 g01.jpg GRAPHIC 85966
  Complete submission text file 0001437749-24-033616.txt   6723948

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ctnm-20240930.xsd EX-101.SCH 42133
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctnm-20240930_cal.xml EX-101.CAL 37994
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctnm-20240930_def.xml EX-101.DEF 322643
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctnm-20240930_lab.xml EX-101.LAB 299474
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctnm-20240930_pre.xml EX-101.PRE 349456
61 EXTRACTED XBRL INSTANCE DOCUMENT cont20240930_10q_htm.xml XML 1206531
Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42001 | Film No.: 241431029
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)